References
- American Heart Association. Heart Disease and Stroke Statistics: 2008 Update At-a-Glance. American Heart Association, TX, USA (2008).
- Prinz von Bayern M, Cadeiras M, Deng MC. Destination therapy: does progress depend on left ventricular assist device development? Heart Fail. Clin.3(1), 349–363 (2007).
- Deng MC, Naka Y. Mechanical Circulatory Support Therapy in Advanced Heart Failure. Imperial College Press, London, UK (2007).
- Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med.345(20), 1435–1443 (2001).
- Deng MC, Edwards L, Hertz M et al. Mechanical circulatory support device database of the international society for heart and lung transplantation: third annual report 2005. J. Heart Lung Transplant.24(9), 1182–1187 (2005).
- Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the Post-REMATCH era implications for patient selection. Circulation116(5), 497–505 (2007).
- Deng MC, Young JB, Stevenson LW et al. Destination mechanical circulatory support: proposal for clinical standards. J. Heart Lung Transplant.22(4), 365–369 (2003).
- Mussivand T. Mechanical circulatory support devices: is it time to focus on the complications, instead of building another new pump? Artificial Organs.32(1), 1–4 (2008).
- Miller LW, Pagani FD, Russell SD et al. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med.357(9), 885–896 (2007).
Websites
- CMS Manual System Pub 100–03 Medicare National Coverage Determinations. 13 April 2007 www.cms.hhs.gov/transmittals/downloads/R68NCD.pdf
- Cardiac Transplantation Research http://cardiactransplantresearch.cumc.columbia.edu